I posted this on 15/3/17
https://hotcopper.com.au/threads/got-burnt-scu.3299229/page-58?post_id=23378220#.WPNMjFN96Rs
I feel it is even more so relevant now. The only saving grace For this company is a well worded fluffy announcement which may spark buying, but I think the market wont fall for this again sadly.
Below are my thought on there latest report, which the only difference was at the time the market cap was $150million
THe company may have potential, But pumped to a market Cap of $149Million? just on the company making a well timed announcement that they are going to be entering the MM field.
"THE BELOW IS MY OPINION, I AM NOT A ACCOUNTANT SO READ THE REPORTS YOURSELF, ALL IS IN MY OPINION AND INTERPRETATION OF THE HALF YEARLYREPORT"
2016 Half Yearly Report
$174K Profit, up from a $439k loss in 2015
$312K in Cash
NET ASSETS of $4.8Million of WHich 4.44Million is a INTANGELIBLE ASSET OF Intellectual property – Dendrobium Officinale meristematic plant cells and method of isolating them (THIS ASSET WAS INDEPENDENTLY EVALUATED)
I, In my Opinion do Not like this Half Yearly Report
From 14th April 2017 Ann. Not sure how this is accurate
“SCU is uniquely placed in terms of technology and expertise to advance in the Medicinal Cannabis market over the coming years.”
This below statement is troubling, as almost all medical marijuana products for Epilipsey, Sever pain is from Extract, so saying that there Advisor was referenced in High Times for growing different Marijuana strains is not really relevant. Considering that different strains is far more important for Recreational Marijuana . There are numerous growers experimenting with different strains to improve highs, different kind of recreational affects. Nothing new here at all.
Mr. Schoenmakers was referenced in the industry magazine High Times as the "King of Cannabis", and he brings a wealth of sector experience to SCU. He was the first cannabis cultivator to export cannabis seeds from the Netherlands to global markets, and he is credited with creating many of the most popular award winning strains.
BOILS DOWN TO THIS IN MY OPINION
"I AM NOT A ACCOUNTANT SO READ THE REPORTS YOURSELF, ALL IS IN MY OPINION AND INTERPRETATION OF THE Half YEAR REPORT"
$312K In cash,
A Intangible Asset of $4.8Million
A Profit of 174K FOr Dec 2016 Half Year, ONLY DUE TO A Accounting of COunting a Director Fee Waiver of 338,353 as a + to the balance SHeet
MARKET CAP OF $150MILLION Hmmmm..............
"I AM NOT A ACCOUNTANT SO READ THE REPORTS YOURSELF, ALL IS IN MY OPINION AND INTERPRETATION OF THE ANNUAL REPORT"
(20min delay)